{"Data":[{"AccessibilityStatusID":1,"DocumentDescription":"Signed","DocumentFormat":"(PDF, 195 KB) ","DocumentID":15327,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Request for Action 2024 Annual Program Budget","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"Signed","DocumentFormat":"(PDF, 211 KB) ","DocumentID":15374,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Request for Action 2022 Annual Report","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 6,140 KB) ","DocumentID":15201,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Annual Report","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 22 KB) ","DocumentID":15204,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Annual Report Attachment C","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 51 KB) ","DocumentID":15206,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Annual Report Attachment E","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 23 KB) ","DocumentID":15208,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Annual Report Attachment G","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 29 KB) ","DocumentID":15210,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Annual Report Attachment H","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 27 KB) ","DocumentID":15209,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Annual Report Attachment I","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 2,956 KB) ","DocumentID":15211,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Annual Report Attachment J","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 131 KB) ","DocumentID":15212,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Annual Report Attachment K","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 317 KB) ","DocumentID":15213,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2024 Annual Program Budget","PRAStatusID":2,"StorageKey":null},{"AccessibilityStatusID":1,"DocumentDescription":"","DocumentFormat":"(PDF, 462 KB) ","DocumentID":15218,"DocumentPath":null,"DocumentSize":null,"DocumentTitle":"Covered Drugs 2022 Independent Financial Audit","PRAStatusID":2,"StorageKey":null}],"Total":12,"AggregateResults":null,"Errors":null}